280 related articles for article (PubMed ID: 34552163)
1. Multimodal deep learning models for the prediction of pathologic response to neoadjuvant chemotherapy in breast cancer.
Joo S; Ko ES; Kwon S; Jeon E; Jung H; Kim JY; Chung MJ; Im YH
Sci Rep; 2021 Sep; 11(1):18800. PubMed ID: 34552163
[TBL] [Abstract][Full Text] [Related]
2. Prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer using a deep learning (DL) method.
Qu YH; Zhu HT; Cao K; Li XT; Ye M; Sun YS
Thorac Cancer; 2020 Mar; 11(3):651-658. PubMed ID: 31944571
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment ultrasound-based deep learning radiomics model for the early prediction of pathologic response to neoadjuvant chemotherapy in breast cancer.
Yu FH; Miao SM; Li CY; Hang J; Deng J; Ye XH; Liu Y
Eur Radiol; 2023 Aug; 33(8):5634-5644. PubMed ID: 36976336
[TBL] [Abstract][Full Text] [Related]
4. Multi-input deep learning architecture for predicting breast tumor response to chemotherapy using quantitative MR images.
El Adoui M; Drisis S; Benjelloun M
Int J Comput Assist Radiol Surg; 2020 Sep; 15(9):1491-1500. PubMed ID: 32556920
[TBL] [Abstract][Full Text] [Related]
5. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
[TBL] [Abstract][Full Text] [Related]
6. Texture Analysis with 3.0-T MRI for Association of Response to Neoadjuvant Chemotherapy in Breast Cancer.
Eun NL; Kang D; Son EJ; Park JS; Youk JH; Kim JA; Gweon HM
Radiology; 2020 Jan; 294(1):31-41. PubMed ID: 31769740
[TBL] [Abstract][Full Text] [Related]
7. Deep Learning of Multimodal Ultrasound: Stratifying the Response to Neoadjuvant Chemotherapy in Breast Cancer Before Treatment.
Gu J; Zhong X; Fang C; Lou W; Fu P; Woodruff HC; Wang B; Jiang T; Lambin P
Oncologist; 2024 Feb; 29(2):e187-e197. PubMed ID: 37669223
[TBL] [Abstract][Full Text] [Related]
8. Deep learning with biopsy whole slide images for pretreatment prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer：A multicenter study.
Li B; Li F; Liu Z; Xu F; Ye G; Li W; Zhang Y; Zhu T; Shao L; Chen C; Sun C; Qiu B; Bu H; Wang K; Tian J
Breast; 2022 Dec; 66():183-190. PubMed ID: 36308926
[TBL] [Abstract][Full Text] [Related]
9. Features from Computerized Texture Analysis of Breast Cancers at Pretreatment MR Imaging Are Associated with Response to Neoadjuvant Chemotherapy.
Chamming's F; Ueno Y; Ferré R; Kao E; Jannot AS; Chong J; Omeroglu A; Mesurolle B; Reinhold C; Gallix B
Radiology; 2018 Feb; 286(2):412-420. PubMed ID: 28980886
[TBL] [Abstract][Full Text] [Related]
10. A hierarchical self-attention-guided deep learning framework to predict breast cancer response to chemotherapy using pre-treatment tumor biopsies.
Saednia K; Tran WT; Sadeghi-Naini A
Med Phys; 2023 Dec; 50(12):7852-7864. PubMed ID: 37403567
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Tumor Response After Neoadjuvant Chemotherapy in Breast Cancer Patients: Correlation Between Dynamic Contrast-enhanced Magnetic Resonance Imaging and Pathologic Tumor Cellularity.
Choi WJ; Kim WK; Shin HJ; Cha JH; Chae EY; Kim HH
Clin Breast Cancer; 2018 Feb; 18(1):e115-e121. PubMed ID: 28890184
[TBL] [Abstract][Full Text] [Related]
12. Prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer using radiomics of pretreatment dynamic contrast-enhanced MRI.
Yoshida K; Kawashima H; Kannon T; Tajima A; Ohno N; Terada K; Takamatsu A; Adachi H; Ohno M; Miyati T; Ishikawa S; Ikeda H; Gabata T
Magn Reson Imaging; 2022 Oct; 92():19-25. PubMed ID: 35636571
[TBL] [Abstract][Full Text] [Related]
13. Texture analysis using machine learning-based 3-T magnetic resonance imaging for predicting recurrence in breast cancer patients treated with neoadjuvant chemotherapy.
Eun NL; Kang D; Son EJ; Youk JH; Kim JA; Gweon HM
Eur Radiol; 2021 Sep; 31(9):6916-6928. PubMed ID: 33693994
[TBL] [Abstract][Full Text] [Related]
14. Imaging and Clinicopathologic Features Associated With Pathologic Complete Response in HER2-positive Breast Cancer Receiving Neoadjuvant Chemotherapy With Dual HER2 Blockade.
Yoon GY; Chae EY; Cha JH; Shin HJ; Choi WJ; Kim HH; Kim JE; Kim SB
Clin Breast Cancer; 2020 Feb; 20(1):25-32. PubMed ID: 31519449
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound-based deep learning radiomics in the assessment of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer.
Jiang M; Li CL; Luo XM; Chuan ZR; Lv WZ; Li X; Cui XW; Dietrich CF
Eur J Cancer; 2021 Apr; 147():95-105. PubMed ID: 33639324
[TBL] [Abstract][Full Text] [Related]
16. New Explainable Deep CNN Design for Classifying Breast Tumor Response Over Neoadjuvant Chemotherapy.
Adoui ME; Drisis S; Benjelloun M
Curr Med Imaging; 2022; 19(5):526-533. PubMed ID: 36529908
[TBL] [Abstract][Full Text] [Related]
17. Prediction of pathological complete response using radiomics on MRI in patients with breast cancer undergoing neoadjuvant pharmacotherapy.
Kuramoto Y; Wada N; Uchiyama Y
Int J Comput Assist Radiol Surg; 2022 Apr; 17(4):619-625. PubMed ID: 35023018
[TBL] [Abstract][Full Text] [Related]
18. Deep learning-based predictive biomarker of pathological complete response to neoadjuvant chemotherapy from histological images in breast cancer.
Li F; Yang Y; Wei Y; He P; Chen J; Zheng Z; Bu H
J Transl Med; 2021 Aug; 19(1):348. PubMed ID: 34399795
[TBL] [Abstract][Full Text] [Related]
19. Machine learning classification of texture features of MRI breast tumor and peri-tumor of combined pre- and early treatment predicts pathologic complete response.
Hussain L; Huang P; Nguyen T; Lone KJ; Ali A; Khan MS; Li H; Suh DY; Duong TQ
Biomed Eng Online; 2021 Jun; 20(1):63. PubMed ID: 34183038
[TBL] [Abstract][Full Text] [Related]
20. Deep learning radiomics of ultrasonography can predict response to neoadjuvant chemotherapy in breast cancer at an early stage of treatment: a prospective study.
Gu J; Tong T; He C; Xu M; Yang X; Tian J; Jiang T; Wang K
Eur Radiol; 2022 Mar; 32(3):2099-2109. PubMed ID: 34654965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
